Naoto T. Ueno
- Cancer Research top 0.05%
- Breast Cancer Treatment Studies 143
- Cancer Genomics and Diagnostics 52
- Oncology top 0.05%
- HER2/EGFR in Cancer Research 114
- Cancer Cells and Metastasis 91
- Cancer Treatment and Pharmacology 63
- Cancer Immunotherapy and Biomarkers 47
- Hematology top 0.1%
- Hematopoietic Stem Cell Transplantation 38
- Immunology top 0.5%
- Pathology and Forensic Medicine top 0.2%
-
- Advanced Breast Cancer Therapies 52
- Co-authors
- Gabriel N. HortobágyiWendy A. WoodwardVicente ValeroMassimo CristofanilliJames M. ReubenRichard E. ChamplinSergio GiraltBora Lim
- Cited by
- Cancer ResearchOncologyHematology
- Partner nations
- United StatesJapanUnited Kingdom
In The Last Decade
Naoto T. Ueno
522 papers receiving 20.1k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Cancer Research 6.5k
- Oncology 11.0k
- Hematology 3.3k
- Immunology 2.6k
- Pathology and Forensic Medicine 2.2k
Countries citing papers authored by Naoto T. Ueno
This map shows the geographic impact of Naoto T. Ueno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoto T. Ueno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoto T. Ueno more than expected).
Fields of papers citing papers by Naoto T. Ueno
This network shows the impact of papers produced by Naoto T. Ueno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoto T. Ueno. The network helps show where Naoto T. Ueno may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Naoto T. Ueno, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 2 | |
| 3 | 2022 | 36 | |
| 4 | 2020 | 20 | |
| 5 | 2020 | 51 | |
| 6 | 2019 | 10 | |
| 7 | 2018 | 71 | |
| 8 | 2017 | 40 | |
| 9 | 2017 | 49 | |
| 10 | 2015 | 59 | |
| 11 | 2015 | 17 | |
| 12 | 2014 | 28 | |
| 13 | Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypesbreakdown → | 2013 | 525 |
| 14 | 2013 | 14 | |
| 15 | 2013 | 65 | |
| 16 | 2010 | 17 | |
| 17 | 2009 | 98 | |
| 18 | 2009 | 30 | |
| 19 | 2008 | 215 | |
| 20 | 2008 | 60 |
About Naoto T. Ueno
Naoto T. Ueno is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 547 papers that have together received 20.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (143 papers), HER2/EGFR in Cancer Research (114 papers), Cancer Cells and Metastasis (91 papers), Cancer Treatment and Pharmacology (63 papers), Cancer Genomics and Diagnostics (52 papers), Advanced Breast Cancer Therapies (52 papers), Cancer Immunotherapy and Biomarkers (47 papers) and Hematopoietic Stem Cell Transplantation (38 papers). The work is most often cited by research in Cancer Research (6.5k citations), Oncology (11.0k citations) and Hematology (3.3k citations). Naoto T. Ueno has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Gabriel N. Hortobágyi, Wendy A. Woodward, Vicente Valero, Massimo Cristofanilli, James M. Reuben, Richard E. Champlin, Sergio Giralt, Bora Lim, Dongwei Zhang and Hiroko Masuda.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.